Published in Virology on February 01, 1978
Vaccinia virus replication. I. Requirement for the host-cell nucleus. J Virol (1979) 3.10
Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis. J Virol (1996) 2.77
Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant. J Virol (2000) 2.20
Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J Virol (1995) 1.85
Deep-etch EM reveals that the early poxvirus envelope is a single membrane bilayer stabilized by a geodetic "honeycomb" surface coat. J Cell Biol (2005) 1.73
Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells. Proc Natl Acad Sci U S A (1986) 1.71
Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component. J Virol (1993) 1.68
Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J Virol (1995) 1.62
External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice. J Cell Biol (2005) 1.55
Isolation and genetic characterization of temperature-sensitive mutants of vaccinia virus WR. J Virol (1982) 1.54
Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53
DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles. J Virol (1998) 1.44
Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane. J Virol (2005) 1.39
Characterization of a temperature-sensitive mutant of vaccinia virus reveals a novel function that prevents virus-induced breakdown of RNA. J Virol (1985) 1.32
Vaccinia virus A30L protein is required for association of viral membranes with dense viroplasm to form immature virions. J Virol (2001) 1.29
Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus. J Virol (1992) 1.28
Detailed phenotypic characterization of five temperature-sensitive mutants in the 22- and 147-kilodalton subunits of vaccinia virus DNA-dependent RNA polymerase. J Virol (1989) 1.27
Marker rescue of temperature-sensitive mutations of vaccinia virus WR: correlation of genetic and physical maps. J Virol (1983) 1.26
Identification of a poxvirus gene encoding a uracil DNA glycosylase. Proc Natl Acad Sci U S A (1993) 1.25
Identification of temperature-sensitive mutants of vaccinia virus that are defective in conversion of concatemeric replicative intermediates to the mature linear DNA genome. J Virol (1989) 1.21
Temperature-sensitive mutations in the vaccinia virus H4 gene encoding a component of the virion RNA polymerase. J Virol (1992) 1.18
A transcriptionally controlled trans-processing assay: putative identification of a vaccinia virus-encoded proteinase which cleaves precursor protein P25K. J Virol (1994) 1.17
The vaccinia virus I1 protein is essential for the assembly of mature virions. J Virol (1997) 1.17
Characterization of vaccinia virus DNA replication mutants with lesions in the D5 gene. Chromosoma (1992) 1.13
The major core protein P4a (A10L gene) of vaccinia virus is essential for correct assembly of viral DNA into the nucleoprotein complex to form immature viral particles. J Virol (2001) 1.07
trans processing of vaccinia virus core proteins. J Virol (1993) 1.06
Biogenesis of poxviruses: role for the DNA-dependent RNA polymerase II of the host during expression of late functions. Proc Natl Acad Sci U S A (1979) 1.05
Phenotypic characterization of temperature-sensitive mutants of vaccinia virus with mutations in a 135,000-Mr subunit of the virion-associated DNA-dependent RNA polymerase. J Virol (1987) 1.03
Biochemical and genetic analysis of the vaccinia virus d5 protein: Multimerization-dependent ATPase activity is required to support viral DNA replication. J Virol (2006) 1.02
Marker rescue mapping of the combined Condit/Dales collection of temperature-sensitive vaccinia virus mutants. Virology (2008) 1.01
Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme. J Biol Chem (2011) 0.99
Unique temperature-sensitive defect in vaccinia virus morphogenesis maps to a single nucleotide substitution in the A30L gene. J Virol (2001) 0.97
A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution. J Virol (1991) 0.96
Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis. Virology (2010) 0.91
Temperature-sensitive mutant in the vaccinia virus E6 protein produce virions that are transcriptionally inactive. Virology (2010) 0.88
Fine structure marker rescue of temperature-sensitive mutations of vaccinia virus within a central conserved region of the genome. J Virol (1985) 0.86
Relationship between RNA polymerase II and efficiency of vaccinia virus replication. J Virol (1989) 0.85
Crystal structure of the vaccinia virus DNA polymerase holoenzyme subunit D4 in complex with the A20 N-terminal domain. PLoS Pathog (2014) 0.85
Capturing the natural diversity of the human antibody response against vaccinia virus. J Virol (2010) 0.84
Genetic Confirmation that the H5 Protein Is Required for Vaccinia Virus DNA Replication. J Virol (2015) 0.80
Analysis of vaccinia virus temperature-sensitive I7L mutants reveals two potential functional domains. Virol J (2006) 0.80
Expression of the highly conserved vaccinia virus E6 protein is required for virion morphogenesis. Virology (2009) 0.79
RNA synthesis and histone acetylation during the course of gene activation in lymphocytes. Proc Natl Acad Sci U S A (1966) 5.06
An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. Virology (1966) 4.03
Vaccinia as a model for membrane biogenesis. Virology (1968) 3.73
Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron (1990) 3.70
Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology (1971) 3.57
Early events in cell-animal virus interactions. Bacteriol Rev (1973) 3.53
Early events in the interaction of adenoviruses with HeLa cells. IV. Association with microtubules and the nuclear pore complex during vectorial movement of the inoculum. Virology (1973) 2.57
Localization of nucleotide phosphohydrolase activity within vaccinia. Proc Natl Acad Sci U S A (1968) 2.47
Two deoxyribonuclease activities within purified vaccinia virus. Proc Natl Acad Sci U S A (1969) 2.46
Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin. Virology (1970) 2.44
The complete DNA sequence of myxoma virus. Virology (1999) 2.44
Pentration of animal viruses into cells. Prog Med Virol (1965) 2.44
Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol (1988) 2.40
Early events in the interaction of adenoviruses with HeLa cells. I. Penetration of type 5 and intracellular release of the DNA genome. Virology (1970) 2.40
Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. J Cell Biol (1996) 2.37
Immunity in hepatitis C infection. J Infect Dis (1992) 2.28
Viropexis of vesicular stomatitis virus by L cells. Virology (1969) 2.17
Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science (1992) 2.07
Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology (1971) 2.06
Penetration and intracellular release of the genomes of avian RNA tumor viruses. Virology (1972) 2.02
Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J Immunol (1988) 2.01
Biogenesis of vaccinia: isolation and characterization of a surface component that elicits antibody suppressing infectivity and cell-cell fusion. Virology (1976) 1.94
Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation (1996) 1.86
Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol (2000) 1.86
Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion. Virology (1979) 1.85
Modulating chemokines: more lessons from viruses. Immunol Today (2000) 1.85
Apoptosis: an innate immune response to virus infection. Trends Microbiol (1999) 1.82
Rapid purification and the immunological specificity of mammalian microtubular paracrystals possessing an ATPase activity. Proc Natl Acad Sci U S A (1970) 1.80
Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res (1995) 1.75
Changing patterns of histone acetylation and RNA synthesis in regeneration of the liver. Proc Natl Acad Sci U S A (1968) 1.73
The complete genome sequence of shope (rabbit) fibroma virus. Virology (1999) 1.73
The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology (1997) 1.72
Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells. Proc Natl Acad Sci U S A (1986) 1.71
Viropexis of herpes simplex virus by HeLa cells. Virology (1969) 1.70
Cytopathology of Mengovirus infection. I. Relationship between cellular disintegration and virulence. Virology (1967) 1.65
T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun (1991) 1.64
Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology (1995) 1.64
Identification of the T4rIIB gene product as a membrane protein. J Mol Biol (1972) 1.62
Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J Virol (1992) 1.59
Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell (1999) 1.56
Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53
The site-specific cleavage of synthetic Holliday junction analogs and related branched DNA structures by bacteriophage T7 endonuclease I. J Biol Chem (1987) 1.52
Biogenesis of poxviruses: genetically controlled modifications of structural and functional components of the plasma membrane. Virology (1974) 1.50
Early events in the interaction of adenoviruses with HeLa cells. 3. Relationship between an ATPase activity in nuclear envelopes and transfer of core material: a hypothesis. Virology (1972) 1.50
High levels of genetic recombination among cotransfected plasmid DNAs in poxvirus-infected mammalian cells. J Virol (1988) 1.50
SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology (1993) 1.49
Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol (1983) 1.46
A poxvirus-encoded uracil DNA glycosylase is essential for virus viability. J Virol (1993) 1.45
Use of chemokine receptors by poxviruses. Science (1999) 1.43
Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line. Environ Health Perspect (1999) 1.43
The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol (1997) 1.43
Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules. Virology (1981) 1.39
M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med (2000) 1.39
Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology (1991) 1.39
Concerning the universality of a microtubule antigen in animal cells. J Cell Biol (1972) 1.39
Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology (1990) 1.38
Identification of a proviral structure in human breast cancer. Cancer Res (2001) 1.37
Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J Virol (1996) 1.37
In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats. Arch Neurol (1980) 1.37
Cytopathology of Mengovirus infection. II. Proliferation of membranous cisternae. Virology (1967) 1.35
Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. J Virol (2005) 1.33
Molecular cloning and characterization of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus. J Biol Chem (1992) 1.33
Biogenesis of poxviruses: mirror-image deletions in vaccinia virus DNA. Cell (1979) 1.30
Effects of streptovitacin A on the initial events in the replication of vaccinia and reovirus. Proc Natl Acad Sci U S A (1965) 1.30
Biogenesis of vaccinia: concerning the origin of the envelope phospholipids. Virology (1974) 1.29
Biology of poxviruses. Virol Monogr (1981) 1.29
Regulation of the synthesis of nucleotide phosphohydrolase and neutral deoxyribonuclease: two activities present within purified vaccina virus. Proc Natl Acad Sci U S A (1969) 1.29
Immunomodulation by viruses: the myxoma virus story. Immunol Rev (1999) 1.28
Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology (1996) 1.27
Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc Natl Acad Sci U S A (1996) 1.27
The nucleoporin Nup98 associates with the intranuclear filamentous protein network of TPR. Proc Natl Acad Sci U S A (2001) 1.26
Identification of a poxvirus gene encoding a uracil DNA glycosylase. Proc Natl Acad Sci U S A (1993) 1.25
Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability. J Virol (1996) 1.25
Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology (1996) 1.24
Absence of surface projections of some noninfectious forms of RSV. Virology (1975) 1.24
Distribution and trafficking of JHM coronavirus structural proteins and virions in primary neurons and the OBL-21 neuronal cell line. J Virol (1994) 1.22
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells. Leukemia (2009) 1.22
Early events in the interaction of adenoviruses with HeLa cells. II. Comparative observations on the penetration of types 1, 5, 7, and 12. Virology (1970) 1.22
Wnt signaling regulates the function of MyoD and myogenin. J Biol Chem (2000) 1.22
Mechanism of replication of phi x174 single-stranded DNA. IX. Requirement for the Escherichia coli dnaG protein. J Virol (1974) 1.21
In vivo and in vitro models of demyelinating diseases: tropism of the JHM strain of murine hepatitis virus for cells of glial origin. Cell (1977) 1.20
Identification and DNA sequence of the large subunit of the capping enzyme from Shope fibroma virus. Virology (1991) 1.19
The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha. Mol Cell Biol (1987) 1.19
Biogenesis of vaccinia: separation of early stages from maturation by means of hydroxyurea. Virology (1971) 1.17
Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J Virol (1987) 1.16
Physical characterization and molecular cloning of the Shope fibroma virus DNA genome. Virology (1983) 1.16
Tumorigenic poxviruses: analysis of viral DNA sequences implicated in the tumorigenicity of Shope fibroma virus and malignant rabbit virus. Virology (1986) 1.16
Initiation and termination of vaccinia virus DNA replication. Virology (1981) 1.15
Immunomodulatory proteins of myxoma virus. Semin Immunol (2001) 1.14
Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. J Biol Chem (1998) 1.12
The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest (2000) 1.12
Involvement of spicules in the formation of vaccinia virus envelopes elucidated by a conditional lethal mutant. Virology (1995) 1.11
Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs. Am J Vet Res (1996) 1.09
Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology (1987) 1.09